Fexofenadine HCl Tablets — Class II drug recall D-1877-2019
Terminated recall by Preferred Pharmaceuticals, Inc, reported 2019-10-02, distributed in FL. Failed Impurities/Degradation Specifications
| Recall number | D-1877-2019 |
|---|---|
| Product type | Drug |
| Classification | Class II |
| Status | Terminated |
| Voluntary or mandated | Voluntary |
| Recalling firm | Preferred Pharmaceuticals, Inc, Anaheim, CA, United States |
| Recall initiated | 2019-08-29 |
| Classified | 2019-09-24 |
| Reported by FDA | 2019-10-02 |
| Terminated | 2023-04-24 |
| Distributed | FL |
| Quantity | 79 |
| Reason classes | specification failure |
| NDC | 68788-6848-09 |
| Lot numbers | C1419E, G0219K |
| Expiration dates | 2021-03 |
Product
Fexofenadine HCl Tablets, 180 mg, Pkg Size 90, Mfg: Aurohealth LLC, Repackaged by Preferred Pharmaceuticals, Inc., Anaheim, CA, NDC #: 68788-6848-09
Reason for recall
Failed Impurities/Degradation Specifications
Machine access
This record, with every extracted code, the verbatim FDA record and provenance, is available from the recall API: GET https://api.data.aroqon.com/v1/recalls/D-1877-2019. Look up any UPC, UDI, NDC or lot with /v1/recalls/lookup?code=…. API docs · free and paid keys.
Source: U.S. Food and Drug Administration enforcement report via openFDA (CC0). Structured by Data Foundry (recall-structuring@2); last changed 2026-09-26. Not affiliated with or endorsed by FDA. Not medical or legal advice.